In spite of initial skepticism, new advancements in peptide drug discovery have rejuvenated desire in peptides as therapeutic brokers, with about 70 peptides now marketed and several other Other people in clinical development. These procedures open up new avenues for treatment options personalized to fight precise breast cancer subtypes and glio